Mettler-Toledo (MTD) Q3 2026 earnings review
Mettler-Toledo's lab sales recover, and its China business grows 13%
Mettler-Toledo, the maker of laboratory balances and industrial scales, sold more across almost all of its businesses. Sales rose 6%, excluding currency swings, ahead of its own plan, with Asia supplying most of the gain. Profit per share excluding one-offs grew about twice as fast as sales, helped by buybacks. Chief executive Patrick Kaltenbach raised this year's outlook and set a first 2027 plan of about 5% sales growth.
| Sales growth, excluding currency swings | 6% plan: about 4% |
|---|---|
| Profit per share, excluding one-offs | $12.57 +13% from a year ago |
| Sales growth in China | 13% 9% last quarter |
| Full-year outlook | Raised profit per share $47.70–47.90, about 12% growth |
⚖️ Verdict: 🟢 Bullish
The story got better because lab demand is recovering and the 2027 plan holds growth at this year's pace. Finance chief Shawn Vadala said that plan counts no help from new US factories. One caution: he expects China growth to ease to mid-single digits next year.
The question now is whether lab customers are replacing old instruments or simply buying again after a weak stretch. A replacement wave could lift growth above the plan; an ordinary recovery would keep it near the plan. Lab sales in the first half of 2027 will tell.
🐂 Bull Case
China Sales Grew 13% Across Lab and Industry
China brings in about a sixth of Mettler-Toledo's sales, finance chief Shawn Vadala said. The recovery there began with industrial products for factory automation, so the worry was that it rested on factory spending, which can reverse quickly.
This quarter lab sales joined in. Vadala said industrial sales in China grew in the "mid-teens" and lab sales at "a very, very high single digit" rate. Chief executive Patrick Kaltenbach credited an "in China for China strategy", with local factories and a local sales team.
- China sales growth: 4% in the first quarter, 9% in the second, 13% in the third
- China plan for the fourth quarter: mid-teens growth in both lab and industrial
- China plan for 2027: mid-single-digit growth
- Other emerging markets: about 17% of sales, growing by double digits
Growth in two businesses at once makes a sudden reversal less likely. But Vadala plans slower growth in China for 2027, because the strong second half of 2026 sets a hard comparison for next year.
What to watch: China lab growth in the fourth quarter, due with the results in early 2027. Mid-teens growth in lab sales would show the recovery no longer depends on factory spending.
Lab Sales Recover as Biotech Customers Return
The laboratory unit sells balances, pipettes and analytical instruments, and brings in more than half of Mettler-Toledo's sales. Sales from businesses it owned a year ago rose 6% there, and chief executive Patrick Kaltenbach said growth reached nearly all product areas.
Biotech research customers came back, which led to "very strong growth in our liquid handling business", the pipettes and tips the unit sells. Finance chief Shawn Vadala said liquid handling is one of the group's better-margin businesses, so the recovery also lifts profit.
What to watch: lab growth in the first half of 2027, against a plan for mid-to-high single digits. Faster growth would show customers replacing the many instruments they bought in 2021 and 2022, which Vadala has not built into the plan.
The 2027 Plan Keeps This Year's Growth Pace
Each autumn Mettler-Toledo sets a first plan for the next year. The plan for 2026 assumed markets would not improve, and it has raised its profit outlook in every quarter since. The third quarter again topped the quarterly profit plan by a typical margin.
Finance chief Shawn Vadala now expects sales to grow about 5% in 2027, excluding currency swings, the same as this year. He expects price increases of a little over 2%, so selling more units supplies about 3%.
- Lab: mid-to-high single-digit growth
- Core industrial, its scales and weighing systems for factories: mid-single-digit growth
- Product inspection, machines that check food for contamination: low-to-mid single-digit growth
- Food retail: low single-digit growth
This matters because the plan leaves out several possible gains. Vadala said onshoring, companies moving production back to the US, is not "meaningful to our 2027 results", and he built in no faster replacement of old instruments. But the plan leans on the Americas, because he is cautious on Europe and China.
What to watch: the 2027 plan when Mettler-Toledo updates it with fourth-quarter results in early 2027. Another early raise, as happened through 2026, would show the company again set a cautious starting point.
🐻 Bear Case
Buybacks Lift Profit Per Share More Than Operations
"Improved sales volume and strong execution of our strategic initiatives resulted in another quarter of robust growth in Adjusted EPS," chief executive Patrick Kaltenbach said.
Operating profit excluding one-offs grew 8%. Profit per share on the same basis climbed 13%, because the share count shrank and interest and tax costs fell. Mettler-Toledo spent $226 million buying back its own stock in the quarter.
This matters because buybacks absorb almost all the cash the business makes. Finance chief Shawn Vadala plans about $950 million of buybacks in 2027, matching the free cash flow he expects, so a weak year would leave little spare cash.
What to watch: operating profit growth against profit-per-share growth in the fourth quarter. A gap this wide again would show buybacks still drive much of the gain in earnings.
Growth Slows to 5% in the Fourth Quarter
Mettler-Toledo expects sales to rise about 5% in the fourth quarter, excluding currency swings, after 6% in the third, because two smaller units face strong results from a year ago.
Food retail shrank 2% because of the "timing of project activity", chief executive Patrick Kaltenbach said. Finance chief Shawn Vadala expects a mid-single-digit drop next quarter, as the unit is "lapping a really big comp". Product inspection, machines that check food for contamination, grew 8%, but he sees it "more flattish".
This matters because Mettler-Toledo holds only about "1.5 months of backlog", so project timing moves its results quickly. Sales in the Americas rose just 3%, partly on slower food retail projects.
What to watch: fourth-quarter sales growth, due in early 2027. A result of 6% or more would show lab and industrial demand outran these weak spots.
Gross Margin Gains Stop in 2027
Gross margin, the share of sales left after the cost of making products, widened 0.6 percentage points. Finance chief Shawn Vadala credited price increases of just over 2.5%, lower US tariffs than a year ago and higher volume.
Costs pushed the other way. Vadala cited "higher material and transportation costs", and selling and administrative costs reached 24.4% of sales, 0.3 points above a year ago, on sales investments and bigger bonuses.
That help fades in 2027: Vadala expects gross margin to be "flattish" as price increases slow to a little over 2%. The plan also assumes US import tariffs "go back to the previous IEPA rates", so any tariff change would cut margin directly.
What to watch: gross margin in the first quarter of 2027. A figure below 58.7%, the level of early 2026, would mean costs now outrun price increases.
Risks this quarter didn't answer
Three standing concerns got no new numbers in the quarter, so each still waits for a later reading from Mettler-Toledo or its customers.
- Middle East conflict: finance chief Shawn Vadala said the plan includes no escalation and customers have not changed their behaviour; a sudden pause in orders would show it within weeks.
- Onshoring, companies building new plants in the US: chief executive Patrick Kaltenbach expects it to "contribute in the second half of 2027 and the years ahead"; first sales from those projects would move this concern.
- Orders: the company still reports no order or backlog figure in dollars; a published figure would show whether demand is building ahead of sales.
👓 Other Themes
Europe Grows 2% While Its Economy Stays Weak
Sales in Europe rose 2%, excluding currency swings, and chief executive Patrick Kaltenbach said the modest growth reached across the portfolio. He said "macroeconomic conditions remain subdued". Finance chief Shawn Vadala plans only low single-digit growth there in 2027, citing energy costs and trade disputes, and called Europe the region he watches most closely.
New Launches in Bioprocessing, Food Safety and Pipettes
Mettler-Toledo added several products this quarter. A new online bioburden analyzer provides "real time monitoring of microbial contamination", for example in water systems at drug plants. Chief executive Patrick Kaltenbach said the group also introduced "AI enabled image recognition software for our X-ray systems" and new electronic pipettes with "PFAS free tips". None of the launches has a sales figure yet.
💲 Other KPIs
Free cash flow excluding one-offs fell 5% over the first nine months, and finance chief Shawn Vadala blamed $72 million of higher tax payments. Without them, the total would have grown about 5% by our math. In the third quarter alone, cash flow rose 2%.
Inventories grew faster than sales: up 9% from a year ago, against sales up 6%. The gap has narrowed since December, when stock stood 13% above a year earlier. The extra stock ties up cash, so a slower build in the fourth quarter would help free cash flow.
Service revenue, the work Mettler-Toledo does on instruments customers already own, grew 7%, Vadala said. That matches the first quarter and trails the second quarter's 9%, but it still runs above the group's total growth rate. Service steadies results, because it depends less on new equipment budgets.
🔮 Guidance
New. The plan has sales growing about 5% in the fourth quarter, a step down from 6% in the third. Finance chief Shawn Vadala expects price increases of about 2.5% to continue, so higher volume supplies the rest. Food retail and product inspection face hard comparisons from a year ago.
New. The plan has profit per share growing 11–13%, slightly slower than in the third quarter. By our math, the middle of the range sits $0.06 above what the earlier full-year outlook implied for this quarter. If the pattern of beats holds, by our math the quarter would land near $15.60.
Raised. The plan now has sales growing about 5% this year, or about 4% from businesses owned a year ago. It is the second raise, after the plan sat at about 4% for its first three versions. The first nine months reached 5%, so the fourth quarter needs only the same pace.
Raised. Profit per share should rise about 12% this year. The middle of the range moved up $0.48, close to the $0.50 by which the third quarter topped the middle of its plan. Fourth raise in four quarters: +$0.70, +$0.25, +$0.70, +$0.48.
New. The first plan for 2027 has sales growing about 5%, the same pace as this year. Vadala expects currency to trim reported sales growth by about 1 percentage point and to leave profit per share unchanged. By region, he plans the fastest growth in the Americas, at mid-to-high single digits.
New. The plan has profit per share growing 10–12% in 2027, against about 12% this year. Vadala expects operating margin excluding one-offs to widen about 0.7 percentage points at the middle of the range. A lower tax rate, 18% instead of 19%, also helps. The first plan for 2026 called for 8–9% growth.
❓ Key Questions
How big is bioprocessing, and how fast is it growing?
Mettler-Toledo gives only broad bands for bioprocessing and process analytics, its sensors for drug manufacturing. A dollar figure and growth rate would show how much of the lab recovery comes from new drug-plant capacity.
How much lab growth comes from replacing old instruments?
Vadala pointed to heavy instrument sales in 2021 and 2022 but built no faster replacement into the 2027 plan. A share of lab sales from replacements would show how much room is left.
What is the order backlog in dollars?
The company says it holds about 1.5 months of backlog but gives no figure. Orders and backlog in dollars would show whether demand is building ahead of sales, especially in Europe.
Does the 2026 free cash flow outlook still stand?
Earlier this year the company expected about $900 million of free cash flow for 2026; this quarter it gave only a 2027 figure. Nine-month cash flow trails last year, so the fourth quarter needs a large catch-up.
How much did material and freight costs cut gross margin?
Vadala named higher material and transportation costs as a drag but gave no size. The figure would show how much price increases must cover in 2027, when he expects gross margin to stay roughly flat.